NSE · SGRL
Shree Ganesh Remedies Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#1,602
of 5,004 stocks
🏆 New peak
▲ 101W
Peak #1,602 · 01 Oct 2026
Shree Ganesh Remedies Limited is a smallcap company in the Healthcare space and carries a steep earnings multiple that prices in strong future growth, remains firmly promoter-controlled, with promoters holding 73%, and is growing revenue modestly.
Market Cap
882.14 Cr
P/E Ratio
49.69
P/B Ratio
5.41
ROE
10.90%
ROCE
14.83%
Dividend Yield
—
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 14.36 Cr | 33.20 Cr | 21.11 Cr | 30.32 Cr |
| Net Profit | 1.12 Cr | 6.27 Cr | 3.09 Cr | 4.96 Cr |
| EPS | 0.87 | 4.88 | 2.41 | 3.86 |
| Operating Profit | 1.85 Cr | 9.60 Cr | 4.72 Cr | 7.72 Cr |
Shareholding pattern
Promoter
72.84%
Public
27.16%
PUBLIC BREAKDOWN
DII
0.52%
MF (within DII)
0.00%
Individuals
25.22%
Mutual fund holdings
₹0.01
Cr total
2
Schemes
2
Fund Houses
₹0.01 Cr
Total Exposure
Motilal Oswal Mutual Fund₹0.01 Cr (65.2%)
Bandhan Mutual Fund₹0.00 Cr (34.8%)
Recent corporate actions
No corporate actions on record for this stock.
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.